Latest Form 4 insider transactions

Christopher D Payne, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Rodriguez Felix Matos V., a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.

Sherri Baker, SVP, CFO of Clearwater Paper Corp, reported a transaction in 4,634 shares of common stock on August 15, 2026.

Loren M Starr, a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.

Donna Dorsey, Chief Human Resources Officer of Alight, Inc. / Delaware, reported a transaction in 3,833 shares of common stock on August 15, 2026.

Dale Burks, Chief Commercial Officer & EVP of Standard Motor Products, Inc., sold 12,551 shares of common stock on August 14, 2026.

John Nixon, a Director of Virtu Financial, Inc., sold 9,094 shares of common stock on August 17, 2026 for $60.13 per share.

Tracy P. Palandjian, a Director of Affiliated Managers Group, Inc., reported multiple transactions in common stock on August 15, 2026.

Michael P. Garthwaite, VP (Pres., Products Pipelines) of Kinder Morgan, Inc., sold 1,550 shares of common stock on August 17, 2026 for $32.65 per share.

Eric J Aumen, Chief Accounting Officer of Under Armour, Inc., reported a transaction in 3,568 shares of common stock on August 15, 2026.

Alissa Michelle Starzak, Chief Legal Officer of Cloudflare, Inc., reported a transaction in 3,775 shares of common stock on August 15, 2026.

Lindsay J. Radkoski, CMO, U.S. of Wendy's Co, reported multiple transactions in common stock on August 15, 2026.

Laura Francis, Chief Executive Officer and a Director of SI-BONE, Inc., sold 14,956 shares of common stock on August 17, 2026.

Thomas J Seifert, Chief Financial Officer of Cloudflare, Inc., reported a transaction in 2,944 shares of common stock on August 15, 2026.

Nicholas Donoghoe, EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc., sold 32,710 shares of common stock on August 14, 2026 for $250.00 per share.

David Zawitz, Chief Operating Officer of Verrica Pharmaceuticals Inc., purchased 6,000 shares of common stock on August 17, 2026 for $4.98 per share.

Noah L. Rosenberg, CMO of Verrica Pharmaceuticals Inc., purchased 6,230 shares of common stock on August 17, 2026.

Jayson Rieger, CEO and President and a Director of Verrica Pharmaceuticals Inc., purchased 25,000 shares of common stock on August 14, 2026.

John J. Kirby, Interim CFO of Verrica Pharmaceuticals Inc., purchased 5,000 shares of common stock on August 18, 2026 for $4.93 per share.

James Rolke, Chief Executive Officer and a Director of Revelation Biosciences, Inc., received 208,076 shares of common stock on August 17, 2026.

Hyunsu Jung, See Remarks and a Director of Eyenovia, Inc., reported a transaction in 40,000 shares of common stock on August 16, 2026.

Lakhmir S Chawla, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.

Chester Stanley Zygmont Iii, Chief Financial Officer of Revelation Biosciences, Inc., reported multiple transactions in common stock on August 17, 2026.

Leah Marie Trzcinski, Chief Legal Officer of Donnelley Financial Solutions, Inc., reported a transaction in 1,234 shares of common stock on August 17, 2026.

Jess Roper, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.

Jennifer Carver, a Director of Revelation Biosciences, Inc., received 32,011 shares of common stock on August 17, 2026.

Sylvia Jean Young, a Director of Pediatrix Medical Group, Inc., reported a transaction in 18,500 shares of common stock on August 14, 2026.

Janel Riley, Chief Accounting Officer of Cloudflare, Inc., reported a transaction in 4,135 shares of common stock on August 15, 2026.

Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr of SI-BONE, Inc., sold 3,725 shares of common stock on August 17, 2026.

Scott H Baxter, Chairman and CEO and a Director of Kontoor Brands, Inc., sold 184,403 shares of common stock on August 13, 2026.